Acessa Health announced completion of its bankruptcy buyout of Halt Medical, which includes Halt's Acessa radiofrequency ablation device that is intended for uterine fibroid treatment. Acessa said it also closed the first tranche of a $30 million Series A financing round, which it plans to use for developing next-generation technology, augmenting its clinical portfolio and expanding commercial use of the Acessa procedure.
Halt Medical buyout, first tranche of $30M funding round closed by Acessa
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.